IRADIMED CORP (IRMD) research

IRADIMED CORP
ShareXLinkedInReddit
Sector
Health Care
Last price
$82.12
As of

IRADIMED CORP (IRMD): 3 institutional managers tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 10-Q filed 2026-07-31.

As of . Source: SEC EDGAR filings for IRMD. Method and limitations.

SHARE THIS CARD

Share the IRMD intelligence card

A branded snapshot of IRMD: the smart money composite, cross family confluence, and the top current signal, with a link back to this page. Post it, download it, or embed it anywhere.

Kresmion IRMD intelligence card preview
Post to X
LIVE TERMINAL

See IRMD live in the terminal

Track IRMD's insider trades, 13F flows, options positioning, and cross asset confluence as they update, on one live board. Free account.

Open the live IRMD terminal, free

Active signals for IRMD

FREE, NO ACCOUNT

Every signal on IRMD, as it fires

You are seeing 5 of 11 signals recorded on IRMD since 2026-05-30.

The five above landed across 4 days. The other 6 were recorded on 1 other days. 6 of the 11 are institutional flow rows, which arrive in batches on filing days.

Get it by email

No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.

Join on Telegram
Join on Telegram

One tap. Live alerts, no email needed.

Largest reported share positions in IRMD (2026Q2)

Manager / securityMarket value% portfolioQoQ
RENAISSANCE TECHNOLOGIES LLCCUSIP 46266A109 · 2026Q2$37.7M0.05%,
TWO SIGMA INVESTMENTS, LPCUSIP 46266A109 · 2026Q2$17.5M0.01%,
Point72 Asset Management, L.P.CUSIP 46266A109 · 2026Q2$1.1M0.00%,

Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.

Recent SEC filings, IRMD

IRMD against its peers

IRMD's operating margin of 31.2% ranks in the 98th percentile of 20 Health Care sub-industry peers, fiscal periods ending between 2025-10-03 and 2026-01-02.

MetricIRMDPeer medianPercentilen
Revenue FY83.8M USD789M USD220
Gross margin76.7%54.6%9611
Operating margin31.2%0.9%9820
Net margin26.8%-1.3%9820
Return on equity23.8%-2.8%9820
P / E46.9x47.2x447

Peers (20): STAA, CSTL, PRCT, GDRX, TDOC, USPH, BVS, TALK, TNDM, HSTM, CERT, OMDA, AMN, PNTG, CNMD, VREX, AHCO, OMCL, EHAB, ATEC. Fiscal periods ending between 2025-10-03 and 2026-01-02. Every figure is one full fiscal year read from one annual filing (IRMD: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.

Related tickers

See more IRMD signals as they fire

Kresmion publishes filings, 13F flows, on-chain whale activity, and cross-asset signals in real time. Open a live board scoped to IRMDand get the insider, 13F, options, and confluence read in one view.

Open the live IRMD terminal, free